Bioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone

Clinical trial NCT07046975 · COMPLETED

Trial details

NCT number: NCT07046975
Sponsor: Sarfez Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bioavailability Heathy Volunteers

Start date: 2025-06-15
Primary completion: 2026-02-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.